Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy

Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy

Abstract Background To evaluate the efficacy and safety of intravitreal conbercept (KH902) as the primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy. Methods This study was a retrospective, consecutive, observational case series. We reviewed medical records o...

Full description

Bibliographic Details
Main Authors: Yuting Peng, Xiongze Zhang, Lan Mi, Bing Liu, Chengguo Zuo, Miaoling Li, Feng Wen
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Ophthalmology
Subjects:
Conbercept
KH902
Intravitreal injection
Choroidal neovascularization
Punctate inner choroidopathy
Efficacy
Online Access:http://link.springer.com/article/10.1186/s12886-017-0481-8

Internet

http://link.springer.com/article/10.1186/s12886-017-0481-8

Similar Items